Pharmaceuticals · Market statistics

Autologous Matrix-induced Chondrogenesis market statistics

Size and growth in 33 countries and regions, with clinical trials and research from public sources.

Most clinical trials

Active trials by country (ClinicalTrials.gov)

  1. 1 US 22
  2. 2 China 13
  3. 3 Italy 11
  4. 4 Canada 9
  5. 5 Germany 6
  6. 6 France 5
  7. 7 UK 5
  8. 8 Mexico 3
See every trial on ClinicalTrials.gov (opens in a new tab)

Autologous Matrix-induced Chondrogenesis by country and region

Autologous Matrix-induced Chondrogenesis market size, growth and active trials in every geography we cover
Place20232033 (projected)CAGR Active trialsReport
World – – – 100 Report on Autologous Matrix-induced Chondrogenesis in Global
APAC – – – 15 Report on Autologous Matrix-induced Chondrogenesis in APAC
Africa – – – 2 Report on Autologous Matrix-induced Chondrogenesis in Africa
Europe – – – 22 Report on Autologous Matrix-induced Chondrogenesis in Europe
Latin America – – – 4 Report on Autologous Matrix-induced Chondrogenesis in Latin America
Middle East – – – 0 Report on Autologous Matrix-induced Chondrogenesis in Middle East
North America – – – 27 Report on Autologous Matrix-induced Chondrogenesis in North America
Australia – – – 1 Report on Autologous Matrix-induced Chondrogenesis in Australia
Brazil – – – 2 Report on Autologous Matrix-induced Chondrogenesis in Brazil
Canada – – – 9 Report on Autologous Matrix-induced Chondrogenesis in Canada
China – – – 13 Report on Autologous Matrix-induced Chondrogenesis in China
Ecuador – – – 0 Report on Autologous Matrix-induced Chondrogenesis in Ecuador
Egypt – – – 1 Report on Autologous Matrix-induced Chondrogenesis in Egypt
France – – – 5 Report on Autologous Matrix-induced Chondrogenesis in France
Germany – – – 6 Report on Autologous Matrix-induced Chondrogenesis in Germany
Hong Kong – – – 2 Report on Autologous Matrix-induced Chondrogenesis in Hong Kong
India – – – 1 Report on Autologous Matrix-induced Chondrogenesis in India
Italy – – – 11 Report on Autologous Matrix-induced Chondrogenesis in Italy
Japan – – – 1 Report on Autologous Matrix-induced Chondrogenesis in Japan
Kenya – – – 0 Report on Autologous Matrix-induced Chondrogenesis in Kenya
Malaysia – – – 1 Report on Autologous Matrix-induced Chondrogenesis in Malaysia
Mexico – – – 3 Report on Autologous Matrix-induced Chondrogenesis in Mexico
New Zealand – – – 1 Report on Autologous Matrix-induced Chondrogenesis in New Zealand
Philippines – – – 2 Report on Autologous Matrix-induced Chondrogenesis in Philippines
Russia – – – 0 Report on Autologous Matrix-induced Chondrogenesis in Russia
Saudi Arabia – – – 0 Report on Autologous Matrix-induced Chondrogenesis in Saudi Arabia
Singapore – – – 1 Report on Autologous Matrix-induced Chondrogenesis in Singapore
South Africa – – – 1 Report on Autologous Matrix-induced Chondrogenesis in South Africa
Spain – – – 1 Report on Autologous Matrix-induced Chondrogenesis in Spain
Thailand – – – 1 Report on Autologous Matrix-induced Chondrogenesis in Thailand
UAE – – – 0 Report on Autologous Matrix-induced Chondrogenesis in UAE
UK – – – 5 Report on Autologous Matrix-induced Chondrogenesis in UK
US – – – 22 Report on Autologous Matrix-induced Chondrogenesis in US

"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.

Latest research 2,825 papers since 2021

  1. An Iron Disulfide-Decorated Polymeric Carbon Nitride Integrated Photocatalytic Irrigation System Promotes Cartilage Repair via Transient H(2)O(2)-Mediated Immune Regulation. Advanced healthcare materials, 2026
  2. A Pilot Clinical and Experimental Study of Type I Collagen Matrix Implantation Versus Microfracture for Knee Cartilage Defects. Medical science monitor : international medical journal of experimental and clinical research, 2026
  3. Patellofemoral joint cartilage status was not deteriorated after inverted V-shaped high tibial osteotomy. The Knee, 2026
  4. Is Autologous Matrix-Induced Chondrogenesis an Effective Procedure to Treat Cartilage Lesions around the Knee: A Literature Review. Journal of orthopaedic case reports, 2026
  5. Height, Bone Quality, and Osteoarthritis Severity Predict Posterior Cruciate Ligament Footprint Injury Despite Using Robotic-Assisted Technology in Total Knee Arthroplasty. The Journal of arthroplasty, 2026
Search all of them on PubMed (opens in a new tab)

Key companies in Autologous Matrix-induced Chondrogenesis

Anika Therapeutics, Inc B. Braun Melsungen AG BioTissue AG CartiHeal Geistlich Pharma AG JRI Orthopaedics Ltd

Quick answers

How many clinical trials are running in Autologous Matrix-induced Chondrogenesis?

ClinicalTrials.gov lists 100 active trials worldwide (recruiting, about to start or running), most of them in the US, as of 10 Nov 2026.

How much research is published on Autologous Matrix-induced Chondrogenesis?

PubMed lists about 2,825 papers on the topic since 2021.

Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.

Get a free sample The global Autologous Matrix-induced Chondrogenesis report: contents and sample pages, free. Request sample Consult us Need Autologous Matrix-induced Chondrogenesis numbers for your plan? Our analysts can help. Talk to us Buy the report The full global report, $4,000. Every country report is in the table above. Buy now

All market statistics